Sectors:
Min Investment:
Max Investment:
Target Investment:
2016
Focused on building innovative companies to serve patients with significant unmet medical needs. ARTBIO - Board member Asher Biotherapeutics - Board member Candid Therapeutics - Board member Marea Therapeutics - Board member Maze Therapeutics - Board member Rapport Therapeutics (RAPP) - Board member Septerna - Chairman of the board Past companies: Ambys Medicines Nurix (NRIX) Terremoto Biosciences
2016 - 2017
2016 - 2017
Served as Executive Chairman and Chairman through $35M Series A financing and subsequent acquisition by Celgene for $775M with $300M upfront.
2010 - 2016
2010 - 2016
2010 - 2015
2001 - 2010
2001 - 2010
2000 - 2001
2000 - 2001